Fennec Pharmaceuticals (TSE:FRX)
TSX:FRX
Advertisement

Fennec Pharmaceuticals (FRX) Revenue

Compare
28 Followers

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had a revenue of 9.65M in the quarter ending Jun 30, 2025, with 10.30%. This bring the company's revenue in the last twelve months to 33.30M, Decreased 7.73%. In the fiscal year ending Dec 31, 2024, Fennec Pharmaceuticals had annual revenue of 47.54M with 123.69% growth.
Revenue (ttm)
33.30M
Revenue Growth
-19.08%
P/S Ratio
6.67
Revenue/Employee
$1,485,563
Employees
32
Market Cap
$317.00M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
47.54M26.29M+223.69%
Dec 31, 2023
21.25M19.72M+1,384.50%
Dec 31, 2022
1.53M-153,500,000.00%
Dec 31, 2021
-170.00K
Dec 31, 2020
170.00K-17,000,000.00%
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis